UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 12b-25
NOTIFICATION OF LATE FILING
SEC File Number 1-8509 CUSIP Number 630183101
(Check One): [X] Form 10-K [ ] Form 20-F [ ] Form 11-K [ ] Form 10-Q
[ ] Form N-SAR
For Period Ended: December 31, 1999
----------------------
[ ] Transition Report on Form 10-K
[ ] Transition Report on Form 20-F
[ ] Transition Report on Form 11-K
[ ] Transition Report on Form 10-Q
[ ] Transition Report on Form N-SAR
For the Transition Period Ended:______________________________
Read Instruction (on back page) Before Preparing Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission has
verified any information contained herein.
If the notification relates to a portion of the filing checked above, identify
the Item(s) to which the notification relates:
This notification relates to Part I and Part II--Items 6, 7, 8 and 9, and all
Financial Statements and related Financial Schedules.
- --------------------------------------------------------------------------------
PART 1 - REGISTRANT INFORMATION
Augment Systems, Inc.
-----------------------
Full Name of Registrant
N/A
-----
Former Name if Applicable
Address of Principal Executive Office (Street and Number)
22 Bachelor Street
West Newbury, MA 01985
- ----------------------
City, State and Zip Code
PART II - RULES 12b-25(b) AND (c)
If the subject report could not be filed without unreasonable effort or expense
and the registrant seeks relief pursuant to Rule 12b-25(b), the following should
be completed. (Check box if appropriate)
[X] (a) The reasons described in reasonable detail in Part III of this
form could not be eliminated without unreasonable effort or
expense;
<PAGE>
[ ] (b) The subject annual report, semi-annual report, transition
report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR, or portion
thereof, will be filed on or before the fifteenth calendar day
following the prescribed due date; or the subject quarterly report
of transition report on Form 10-Q, or portion thereof will be
filed on or before the fifth calendar day following the prescribed
due date; and
[ ] (c) The accountant's statement or other exhibit required by Rule
12b-25(c) has been attached if applicable.
PART III - NARRATIVE
State below in reasonable detail the reasons why the Form 10-K, 11-K, 10-Q,
N-SAR, or the transition report or portion thereof, could not be filed within
the prescribe time period. (Attach Extra Sheets if Needed)
On January 15, 1999, the Board of Directors of Augment Systems, Inc.
decided to suspend its current operations, reduce its work force to one person
and move to smaller office space. During 1999, the Company attempted to find
companies interested in purchasing technology or acquiring the Company. In March
2000, the Company entered into an agreement to sell a significant portion of the
Company to Right2web, an internet start-up company. The Company's auditors will
complete their field work in March and will be completing the audit by the
middle of April 2000. The Company intends to file its 10-KSB within 15 days from
the end of March.
PART IV - OTHER INFORMATION
(1)Name and telephone number of person to contact in regard to this notification
Duane A. Mayo, Chief Financial Officer 781 270-9678
- --------------------------------------------------------------------------------
(Name) (Area Code) (Telephone Number)
(2)Have all other periodic reports required under Section 13 or 15(d) of the
Securities Exchange Act of 1934 or Section 30 of the Investment Company Act
of 1940 during the preceding 12 months (or for such shorter period that the
registrant was required to file such reports) been filed? If answer is no,
identify report(s). [X] Yes [ ] No
(3)Is it anticipated that any significant change in results of operations from
the corresponding period for the last fiscal year will be reflected by the
earnings statements to be included in the subject report or position thereof?
[X] Yes [ ] No
See disclosure under Part III above.
If so, attach an explanation of the anticipated change, both narratively and
quantitatively, and, if appropriate, state the reasons why a reasonable estimate
of the results cannot be made.
Augment Systems, Inc.
---------------------
(Name of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned
hereunto duly authorized.
Date March 30, 2000 By: s/ Duane A. Mayo
------------------------- ------------------
INSTRUCTION: The form may be signed by an executive officer of the registrant or
by any other duly authorized representative. The name and title of the person
signing the form shall be typed or printed beneath the signature. If the
statement is signed on behalf of the registrant by an authorized representative
(other than an executive officer), evidence of the representative's authority to
sign on behalf of the registrant shall be filed with the form.
ATTENTION
Intentional misstatements or omissions of fact constitute Federal Criminal
Violations (See 18 U.S.C. 1001).
